allergyIn the last few decades, the incidence of such conditions as allergic asthma, allergic rhinoconjunctivitis, and atopic dermatitis, which were once considered rather rare, has risen in patients quite dramatically, affecting approximately 20% of the population. In particular, atopic dermatitis in children has risen from 3% in the 1960′s to a current estimate of 10-15%. Allergic rhinitis has been on the rise as well, accounting for about 20% of the population, whereas allergic asthma accounts for 10%. Therefore, GUNA categorizes allergies as “endemic”. Genetic predisposition to skin sensitivities, exposure, and sensitization are the three variables triggering allergic disease. It is most important to consider the allergic etiopathogenesis as a unit in order to be therapeutically effective with this cluster of pathologies. GUNA’s allergy formulations are based on the theory that homeopathic doses of particular interleukins act on certain lymphocyte surface receptors to restore Th1-Th2 balance, an important technological revelation for atopic therapy. The components of Guna’s allergy remedies perform in a synergistic, therapeutic manner against the allergic condition by altering the “sensitization” of the individual. NOTE: The GUNA formulas incorporate infinitesimal doses of histamine and allergens to gradually modulate the immune hyper-response, thereby performing in a similar fashion as a “vaccine”, with no negative side effects. Download the PDF file

Our range of medicine:
GUNA-ALL-PREV
GUNA-ALL-TREAT
GUNA-RHINO NOSE SPRAY

Registered practitioners, may click on the following link to access detailed product information:
http://gunacanada.com/products/product-information/